The Patent Finder

Method for Fabricating Nanoparticles

Cerulean Pharma Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 61/437,142, filed Jan 28, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,546,521Method for Fabricating Nanoparticles
In force
 · High confidence
Cerulean Pharma Inc.In force
High confidence
US 8,809,492Method For Fabricating Nanoparticles
In force
 · High confidence
Cerulean Pharma Inc.In force
High confidence
Application 14/457,835Method for Fabricating Nanoparticles
Abandoned
Abandoned Nov 9, 2015
Cerulean Pharma Inc.AbandonedAbandoned Nov 9, 2015
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Cerulean Pharma Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited